{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:18:21Z","timestamp":1791177501979,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.mbs.2010.06.005","type":"journal-article","created":{"date-parts":[[2010,7,17]],"date-time":"2010-07-17T08:28:21Z","timestamp":1279355301000},"page":"81-93","source":"Crossref","is-referenced-by-count":28,"title":["Optimal control for resistance and suboptimal response in CML"],"prefix":"10.1016","volume":"227","author":[{"given":"Bedr\u2019Eddine","family":"A\u00efnseba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chahrazed","family":"Benosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mbs.2010.06.005_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.camwa.2008.01.003","article-title":"Numerical integration of a mathematical model of hematopoietic stem cell dynamics","volume":"56","author":"Adimy","year":"2008","journal-title":"Computers and Mathematics with Applications"},{"key":"10.1016\/j.mbs.2010.06.005_bib2","series-title":"Analyse Fonctionnelle","author":"Brezis","year":"1999"},{"key":"10.1016\/j.mbs.2010.06.005_bib3","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2005-03-1240","article-title":"The kinetics of clonal dominance in myeloproliferative disorders","volume":"106","author":"Catlin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.mbs.2010.06.005_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2005.03.033","article-title":"A mathematical model of hematopoiesis: periodic chronic myelogenous leukemia, part I","volume":"237","author":"Colijn","year":"2005","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.mbs.2010.06.005_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.anndiagpath.2006.12.002","article-title":"New insights into the pathobiology and treatment of chronic myelogenous leukemia","volume":"11","author":"Cotta","year":"2007","journal-title":"Annals of Diagnostic Pathology"},{"key":"10.1016\/j.mbs.2010.06.005_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00285-003-0245-3","article-title":"Optimal HIV treatment by maximising immune response","volume":"48","author":"Culshaw","year":"2004","journal-title":"Journal of Mathematical Biology"},{"key":"10.1016\/j.mbs.2010.06.005_bib7","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.2003.11.143","article-title":"Practical management of patients with chronic myeloid leukemia receiving imatinib","volume":"21","author":"Deininger","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.mbs.2010.06.005_bib8","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","article-title":"Successful therapy must eradicate stem cells","volume":"24","author":"Dingli","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.mbs.2010.06.005_bib9","series-title":"Deterministic and Stochastic Optimal Control","author":"Fleming","year":"1975"},{"key":"10.1016\/j.mbs.2010.06.005_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mbs.2010.06.005_bib11","series-title":"Optimal Control, An Introduction to the Theory with Applications","author":"Hocking","year":"1991"},{"key":"10.1016\/j.mbs.2010.06.005_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.emch.2005.07.001","article-title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique","volume":"2","author":"Leguay","year":"2005","journal-title":"EMC-H\u00e9matologie"},{"key":"10.1016\/j.mbs.2010.06.005_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V51.5.941.941","article-title":"A unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis","volume":"51","author":"Mackey","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.mbs.2010.06.005_bib14","series-title":"Physiology and Biofluids","first-page":"149","article-title":"Mathematical models of hematopoietic cell replication and control. The art of mathematical modelling: case studies in ecology","author":"Mackey","year":"1997"},{"key":"10.1016\/j.mbs.2010.06.005_bib15","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukemia","volume":"435","author":"Michor","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mbs.2010.06.005_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mbs.2007.05.003","article-title":"Optimal control of treatment in a mathematical model of chronic myelogenous leukemia","volume":"210","author":"Nanda","year":"2007","journal-title":"Mathematical Biosciences"},{"key":"10.1016\/j.mbs.2010.06.005_bib17","first-page":"225","article-title":"La r\u00e9sistance \u00e0 l\u2019imatinib est-elle toujours li\u00e9e \u00e0 la pr\u00e9sence d\u2019un all\u00e8le bcr-abl mut\u00e9 dans la LMC?","volume":"12","author":"Perot","year":"2006","journal-title":"H\u00e9matologie"},{"key":"10.1016\/j.mbs.2010.06.005_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.crvi.2003.05.004","article-title":"Contribution to the study of periodic chronic myelogenous leukemia","volume":"327","author":"Pujo-Menjouet","year":"2004","journal-title":"Comptes Rendus Biologies"},{"key":"10.1016\/j.mbs.2010.06.005_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1051\/medsci\/200420121125","article-title":"Origine de la r\u00e9sistance au traitement par imatinib m\u00e9sylate","volume":"20","author":"Roche-Lestienne","year":"2004","journal-title":"Medecine\/Sciences"},{"key":"10.1016\/j.mbs.2010.06.005_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nm1487","article-title":"Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications","volume":"12","author":"Roeder","year":"2006","journal-title":"Nature Medecine"},{"key":"10.1016\/j.mbs.2010.06.005_bib21","first-page":"19","article-title":"Crit\u00e8res et traitement des r\u00e9ponses insuffisantes \u00e0 l\u2019imatinib dans la leuc\u00e9mie my\u00e9lo\u00efde chronique","volume":"12","author":"Rousselot","year":"2006","journal-title":"H\u00e9matologie"},{"key":"10.1016\/j.mbs.2010.06.005_bib22","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/sj.onc.1205317","article-title":"Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease","volume":"21","author":"Scheijen","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.mbs.2010.06.005_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.stem.2007.10.016","article-title":"Asymmetric cell division in normal and malignant hematopoietic precursor cells","volume":"1","author":"Schroeder","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.mbs.2010.06.005_bib24","doi-asserted-by":"crossref","unstructured":"M. Tulliez, Traitement de la leuc\u00e9mie my\u00e9lo\u00efde chronique en 2007, Nouvelles approches diagnostiques et th\u00e9rapeutiques en h\u00e9matologie, 25\u201329 (2007).","DOI":"10.1016\/S1773-035X(07)80394-7"},{"key":"10.1016\/j.mbs.2010.06.005_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","article-title":"Imatinib resistance in CML","volume":"274","author":"Volpe","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.mbs.2010.06.005_bib26","unstructured":"N.Widmer, L.A.D\u00e9costerd, Imatinib plasma concentrations variability in hemato-oncologic patients, Th\u00e8se de doctorat, Facult\u00e9 de biologie et de m\u00e9decine de l\u2019Universit\u00e9 de Lausanne, 2006."},{"key":"10.1016\/j.mbs.2010.06.005_bib27","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1016\/j.revmed.2006.09.012","article-title":"Th\u00e9rapeutiques anticanc\u00e9reuses cibl\u00e9es","volume":"27","author":"You","year":"2006","journal-title":"La revue de m\u00e9decine interne"}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556410001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556410001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T04:19:34Z","timestamp":1591503574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556410001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0025556410001070"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2010.06.005","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}